Thomas Sejersen
Associate Professor, Astrid Lindgrens Barnsjukhus
Sweden
Thomas Sejersen holds positions as Professor in Neuropediatrics at the Department of Women’s and Children’s Health of Karolinska Institute and consultant paediatrician at the Astrid Lindgrens Barnsjukhus (Stockholm, Sweden).
He is a paediatric neurologist with special clinical and research interest in neuromuscular disorders. Thomas Sejersen conducts translational and clinical research into congenital myopathies, primarily desmin-related myopathies, spinal muscular atrophy and Duchenne muscular dystrophy, including clinical trials. His major role in TREAT-NMD is the development of standards of care for several paediatric neuromuscular disorders. He is also engaged in validation processes in the NMD-CHIP project, aiming to improve high throughput genetic diagnosis of neuromuscular disorders. Thomas is member of the board of European Paediatric Neurology Society.
Organisations
Karolinska Institute
Karolinska Institute is a longstanding national centre for neuromuscular disorders, involving basic science and clinical research.
Committees
Governing Board Members
Between 2007 and 2011 the TREAT-NMD Governing Board was the official management body whilst the network benefitted from its original EU funding. Respo …
Project Ethics Council – PEC
The Project Ethics Council identifies and examines ethical and social aspects of research taking place in the context of TREAT-NMD.
TREAT-NMD Executive Committee
The TREAT-NMD Executive Committee, made up of 9 academic representatives and 4 patient representatives, took over governance of the network in 2012. T …
TREAT-NMD Task-Force
An academic task force consisting of key clinical and scientific experts from around the world has been established to help develop the future focus a …
Country
